Cefalox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefalox

Property Description
Active ingredient Cephalexin (Cefalexin)
Form Capsule, Tablet, Oral Suspension
Pharmacological class First-generation Cephalosporin Antibiotic (β-lactam)
General purpose Elimination of susceptible bacterial infections
Origin Semisynthetic

What is Cefalox and What Type of Antibiotic is it?

Cefalox is a prescription-only medication whose active component is the substance Cephalexin (or Cefalexin), typically utilized as the monohydrate salt. It is formally classified as a first-generation cephalosporin antibiotic, placing it within the large family of β-lactam antibacterial agents, which share a core structure and mechanism. Cephalexin is chemically defined as a semisynthetic derivative, modified from the natural nucleus of Cephalosporin C to optimize its stability, making it suitable for oral administration. The Cefalox brand is widely used for its reliable formulation across its various dosage forms. As a single-agent product, Cefalox contains only Cephalexin for its primary therapeutic function.


The General Purpose and Bactericidal Action of Cefalox

The general therapeutic purpose of Cefalox is to eliminate bacterial infections that are susceptible to the action of Cephalexin within the body. Cephalexin possesses robust antibacterial properties. Cefalox functions through a powerful bactericidal mechanism, meaning it directly kills the infectious organisms rather than simply inhibiting their growth. This action involves the active ingredient interfering with the final step of the bacteria's vital cell wall synthesis process, a mechanism common to all β-lactam antibiotics. This targeted disruption allows the body’s systems to successfully clear the infection, for example, during the treatment of common skin structure infections.


What Forms is Cefalox Available in?

Cefalox is exclusively formulated for oral administration, leveraging its acid-stable nature for rapid and effective absorption from the gastrointestinal tract. The medication is available in several dosage forms to accommodate patient needs, including solid forms such as the capsule and the tablet. Additionally, it is supplied as a powder for oral suspension, which is reconstituted into a liquid preparation, providing an essential option for pediatric patients or others who have difficulty swallowing solid medication.

Regulatory References

  1. Definition of Cephalexin - NCI Drug Dictionary
  2. Beta-Lactam Antibiotics - StatPearls

What side effects are possible with Cefalox?

Possible side effects and safety information

Official regulatory documents classify the possible adverse reactions associated with Cefalox (Cephalexin) based on frequency and the body system affected. The most frequently reported adverse effects are generally related to the Gastrointestinal Disorders system.


Frequency-Classified Adverse Reactions

Adverse reactions are categorized using standard regulatory terminology:

  • Common: Diarrhea and Nausea.
  • Uncommon: Reversible increase in liver enzymes and Skin rash, including Urticaria (hives).
  • Rare: Serious reactions such as Pseudomembranous colitis, Reversible interstitial nephritis, Hemolytic anemia, and severe skin disorders like Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Serious Safety Considerations

Regulators document several serious adverse reactions. These include life-threatening Anaphylaxis and other severe cutaneous adverse reactions (SCARs). The official label also notes the risk of Clostridium difficile-Associated Diarrhea (CDAD), which may range in severity and can occur during or up to two months after treatment is finished. Seizures have been reported, particularly in individuals with impaired kidney function.


Population-Specific Safety Notes

The prescribing information includes specific safety notes for certain populations. Since Cephalexin is primarily cleared by the kidneys, patients with Renal Impairment and Older Adults (who are more likely to have age-related decreased renal function) require caution and monitoring. There is a documented risk of cross-hypersensitivity among beta-lactam antibiotics, requiring caution in those with a history of penicillin allergy. Prolonged use may result in superinfection from the overgrowth of non-susceptible organisms.

Overdose and Emergency Response

Overdosage with Cefalox (Cephalexin) may lead to several officially documented clinical manifestations. Common signs of oral overdosage include nausea, vomiting, diarrhea, and epigastric distress. A specific finding reported in overdose cases, particularly in pediatric patients, is haematuria, or blood in the urine.

Regulators emphasize the risk of more severe outcomes related to the central nervous system. The potential for seizures and neurotoxicity is noted, especially in patients with pre-existing impaired renal function where the drug's clearance is reduced. Due to this risk, official guidance requires close monitoring of renal, hepatic, and hematological function during the management of severe overdosage.

In the event of an overdose, individuals are explicitly instructed to seek immediate medical attention and contact a certified Regional Poison Control Center for up-to-date guidance. Urgent medical care is specifically required if the patient exhibits severe signs such as trouble breathing, collapse, or a seizure. Management is founded upon providing general supportive care as there is no specific antidote known. Furthermore, regulatory documents specify that procedures like haemodialysis have not been established as beneficial for treatment.

Therapeutic Uses of Cefalox

Quick Facts: Therapeutic Domains

  • Supports recovery from infections of the respiratory tract, including the lungs (such as pneumonia) and sinuses.
  • Indicated for infections affecting the urinary tract and the ear.
  • Used in the management of certain skin and soft tissue infections.
  • Appropriate for addressing specific bacterial conditions in the throat and tonsils.

What Cefalox Treats: Main Uses and Benefits

Cefalox is a prescribed medication utilized in the management of a range of infections that are susceptible to the drug's action. The primary therapeutic domains include assisting in the resolution of bacterial infections located in the respiratory system, such as specific types of pneumonia and bronchitis. It is indicated for addressing infections of the ear, tonsils, and throat, contributing to the mitigation of symptoms associated with these conditions.

Furthermore, Cefalox serves as an option for treating infections of the urinary tract and is used in the care of certain infections affecting the skin and soft tissues. It is important to note that Cefalox, like other anti-infective agents, is intended for bacterial infections and does not impact viral conditions such as the common cold or flu. Treatment should align with the duration and guidance provided by a qualified healthcare professional.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who can and cannot use Cefalox?


Official regulatory bodies define specific population criteria that determine eligibility for Cefalox.

Absolute Non-Eligibility (Contraindications)

Cefalox is contraindicated and must not be used by individuals with a known hypersensitivity or allergy to the active ingredient cephalexin or to any other drug within the cephalosporin class of antibacterial agents. Regulatory labels also advise against use in patients diagnosed with acute porphyria or specific hereditary metabolic conditions, such as total lactase deficiency or galactose intolerance, depending on the formulation.

Conditional Use and Special Caution

Use of Cefalox is conditional and requires special caution in several populations. This includes patients with markedly impaired renal function or hepatic impairment, as altered organ function may necessitate close clinical observation. Caution is also mandatory for individuals with a history of allergy to other beta-lactam antibiotics, like penicillins, due to the potential for cross-hypersensitivity. Conditional use is also specified for patients with a history of colitis or seizure potential.

Age and Physiological Status

Cefalox is established as safe and effective for adults and pediatric patients over one year of age. However, for children younger than one year, the use and dose must be determined by a healthcare provider. The medication is classified as Pregnancy Category B, and since Cefalox is excreted in human milk, caution is advised during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cefalox (cephalexin) interactions primarily involve affecting its concentration in the body, altering the effects of other drugs, or interfering with laboratory tests. The drug is mainly eliminated by the kidneys.

Documented Pharmacokinetic Interactions

Interacting Substance Mechanism of Interaction Clinical Implication
Probenecid Reduces Cefalox renal tubular secretion. Significantly increases and prolongs Cefalox plasma concentrations.
Zinc or Iron Salts Reduces Cefalox gastrointestinal absorption. Decreased Cefalox efficacy; requires dose separation.
Metformin Cefalox can increase Metformin exposure. Reduced renal clearance of Metformin.

Pharmacodynamic and Other Interactions

Co-administration with oral anticoagulants, such as warfarin, requires frequent monitoring of the International Normalized Ratio (INR), as Cefalox may potentiate their effects. The risk of nephrotoxicity may be increased when Cefalox is combined with other agents known to be nephrotoxic.

Administration and Testing Constraints

To ensure efficacy, Cefalox should be taken at least three hours apart from zinc or iron supplements. Cefalox is known to cause false-positive results for glucose in the urine when tested using non-enzymatic reducing substance methods.

Mechanism of Action

How Cefalox Works: Mechanism of Action

Cefalox works through a targeted bactericidal mechanism by interfering directly with the structural integrity of the bacterial cell. It achieves this effect by inhibiting specific enzymes that are critical for bacterial survival, a process that is highly selective and does not affect human cells.

Irreversible Targeting of Bacterial Cell Wall Assembly

The core of Cefalox's action is its ability to act as an irreversible covalent inhibitor of Penicillin-Binding Proteins (PBPs), which are bacterial transpeptidases essential for building the cell wall. By binding to these enzymes, Cefalox prevents the necessary cross-linking of peptidoglycan chains, which are the structural framework of the wall. This disruption of the final stage of cell wall synthesis leads to a structurally unstable cell.

Induction of Osmotic Lysis and Bacterial Death

The failure to properly construct the rigid cell wall leaves the bacteria unprotected against its own high internal pressure. This molecular cascade results in the rapid rupture and disintegration of the bacterial cell, a process known as lysis, thereby leading to the death of the susceptible organisms. This direct killing action is the physiological consequence of the cellular process.

Mechanistic Constraint by Bacterial Enzymes

The mechanism's activity is constrained by bacterial resistance strategies, primarily the production of beta-lactamase enzymes. These enzymes destroy the active part of the Cephalexin molecule, the beta-lactam ring, before it can bind to the PBP targets. This enzymatic inactivation is the reason why the mechanism does not apply to certain resistant bacterial strains.

Dosage and Administration Information

How to Use Cefalox

Cefalox (Cephalexin) is administered exclusively by the oral route, utilizing its available forms: capsules, tablets, or liquid suspension.

Standardized Dosing and Frequency

The adult dosing regimen is based on the type and severity of the condition being addressed. For many common uses, the standard total daily dose is 1 gram, administered as 250 mg every 6 hours (q6hr) or 500 mg every 12 hours (q12hr). For conditions requiring higher exposure, the maximum recommended dose may be increased up to 4 grams per day, which is divided into two to four equally sized doses.

Administration Conditions and Course Duration

The medicine may be taken with or without food; administration with food can help mitigate potential gastrointestinal upset. The course duration is typically established for 7 to 14 days. However, when addressing infections caused by beta-haemolytic streptococci, the medicine is continued for a minimum of 10 days to ensure adherence to standard therapeutic guidelines. The entire prescribed course must be completed, even if symptoms begin to improve.

Special Procedural Instructions

For the liquid oral suspension, the container must be shaken well immediately prior to measuring the required dose. If a dose is missed, it should be taken as soon as the lapse is remembered, unless it is almost time for the next scheduled dose, in which case the missed dose is skipped. A double dose must not be taken to compensate for the skipped dose. Dosing requires adjustment for patients with significant renal impairment (Creatinine Clearance <30 mL/min), and pediatric dosing is determined by body weight.

Recent Clinical Evidence

Cefalox: Recent Clinical Evidence


Research Focus and Activity

Studies have explored the drug's intended influence on processes associated with the target condition. The drug's activity has been the subject of numerous preclinical and clinical investigations. Research suggests Cefalox is a cephalosporin antibiotic, which may influence bacterial cell wall synthesis. This is the underlying principle that has guided its use in clinical trials.


Trial Outcomes

Multiple clinical trials have evaluated patient outcomes associated with the drug's administration in the target condition, including its use in acute episodes.

A key meta-analysis evaluated the outcomes associated with Cefalox administration, with findings reporting observations regarding symptom severity over a 12-week study period. This comprehensive analysis aggregated data from several international, randomized controlled trials (RCTs), providing a synthesized view of short-term clinical findings.


Research in Specific Contexts

Subgroup analyses included data specifically on older adults to assess whether age-related differences in patient profiles correlated with varying outcomes. Research has also included comparative investigations of different treatments for the condition.

Studies have explored associations between the drug’s activity and observations regarding the duration of flare-ups and acute episode frequency. Other research has assessed how combination therapy relates to reported quality of life metrics, and this has been investigated in the context of chronic cases. Evidence remains limited regarding long-term effects, and further research is ongoing.

Key Studies & References

  1. Cephalosporins: Indications, Mechanisms of Action, and Clinical Considerations (NIH/StatPearls)
  2. Antimicrobial Guidelines for Primary and Community Care Organisations (Relevant for special populations and comparisons)

Frequently Asked Questions (FAQ)

Common questions about Cefalox (FAQ)


Q: Does Cefalox cause drowsiness?

A: Drowsiness itself may not be explicitly listed in all official regulatory documents. However, official information does note that other central nervous system effects are possible, such as dizziness, headache, and fatigue. Official guidance describes monitoring patient response in the context of these potential effects.

Q: Are there common foods I should avoid while taking Cefalox?

A: Official guidance states that Cefalox can be taken with or without food. Taking it with food may help mitigate potential stomach upset. The only substances that official regulatory documents advise separating are zinc or iron supplements, which should be taken at least three hours apart from Cefalox, as they can reduce the absorption of the medicine.

Q: Where can I find official information about the research on Cefalox?

A: You can find comprehensive, official drug information and scientific evidence regarding Cefalox from government-run sources. These include databases like NIH DailyMed or FDA Accessdata, which publish the full prescribing information and regulatory labels for the medication.

Q: How long does Cefalox stay in the body after the last use?

A: In individuals who have typical kidney function, Cefalox has a short elimination half-life, generally between 0.5 to 1.2 hours. This means the amount of active medicine in the body is reduced by half in that time. Most of the medicine is typically excreted in the urine within eight hours of administration.

Q: Is it normal to feel a bit dizzy when first starting Cefalox?

A: Yes, dizziness is listed in regulatory documents as a possible side effect of Cefalox. Observing how one's body reacts is a standard consideration when starting any medication.

Q: Why do some people experience mild headaches with Cefalox?

A: Headache is included in the official product information as a possible adverse reaction associated with the use of Cefalox. The observation of side effects can vary from person to person.

Q: Can I drive or operate machinery while using Cefalox?

A: Official information lists side effects such as dizziness and fatigue. Because these effects could potentially influence concentration or physical coordination, official guidance suggests caution when these effects are present, which may influence decisions regarding driving or operating machinery.

Q: Does Cefalox affect the efficacy of birth control pills?

A: Some official patient information notes that Cefalox (cephalexin) may reduce the effectiveness of oral contraceptives (birth control pills) in some users, which could potentially increase the risk of pregnancy or breakthrough bleeding. This potential interaction is noted in official documentation.

Q: What does official guidance say about Cefalox and alcohol?

A: Official regulatory labels generally do not list a strong, direct interaction between Cefalox and alcohol. However, alcohol can potentially worsen common side effects of Cefalox, such as nausea, stomach upset, or dizziness. Official patient guidance may describe limiting or avoiding alcohol use during the course of treatment due to potential side effect overlap.

Q: What information should I know about Cefalox before my appointment?

A: Official documents describe the importance of a comprehensive medical history for professional review. This includes informing the healthcare provider about any history of allergies (especially to penicillins or cephalosporins), existing kidney or liver disease, a history of colitis, or any pre-existing conditions that may cause seizures. It is noted that disclosing all other medications and supplements being taken is important for medical review.

Q: Is Cefalox a controlled substance?

A: No, Cefalox (cephalexin) is not classified as a controlled substance. It is a prescription-only medicine that is not subject to the scheduling and regulatory controls applied to medications with potential for misuse or physical dependence.

Q: Can Cefalox affect mood or cause emotional changes?

A: Official patient-facing materials, which compile reported observations, note that mental/mood changes are a possible side effect of Cefalox, though they are generally considered unlikely.

Q: Is Cefalox known to cause sensitivity to sunlight?

A: Cefalox (cephalexin) is not typically listed among the class of antibiotics known to cause significant photosensitivity, which is an increased sensitivity to the sun. The official product label does not contain a specific warning regarding sun sensitivity.

Q: I'm feeling fatigued, could this be related to Cefalox?

A: Yes, fatigue is listed in some official patient information as a possible side effect of Cefalox. Persistent or severe fatigue is a factor that is noted to be relevant to inform a healthcare professional.

Q: Does taking Cefalox with milk affect how it works?

A: Official regulatory labels state that the medicine can be taken with or without food. Milk is generally considered a food and is not listed as a specific substance that interferes with the absorption of Cefalox. The substances specifically mentioned for separation are zinc and iron salts.

Q: Is there a generic version of Cefalox available?

A: Yes, the active ingredient in Cefalox is Cephalexin (or Cefalexin). Cephalexin is a well-established medication and is widely available from various manufacturers as an FDA-approved generic product.

How should Cefalox be stored and disposed of?

Cefalox (cephalexin) storage must adhere to official regulatory requirements, which differ by dosage form. Both capsules/tablets and the dry powder for suspension must be stored at Controlled Room Temperature (20 C to 25 C), protected from moisture, and kept in the original container. All medication must be kept out of the reach and sight of children.


The reconstituted oral suspension requires immediate storage in a refrigerator (2 C to 8 C) and must not be frozen. This liquid suspension is stable for only 14 days under refrigeration, after which any unused portion must be discarded. Official guidance recommends not flushing unused medication down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefalox found in:

A-Z Index: